Ardent Health, Inc. (NYSE:ARDT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven research firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $19.3273.
Several equities analysts have recently commented on the company. KeyCorp decreased their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Bank of America lowered Ardent Health from a "neutral" rating to an "underperform" rating and decreased their price objective for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. JPMorgan Chase & Co. decreased their price objective on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a report on Monday, August 11th. UBS Group began coverage on Ardent Health in a report on Wednesday, September 10th. They issued a "buy" rating and a $17.00 price objective on the stock. Finally, Wall Street Zen raised Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th.
Read Our Latest Stock Report on ARDT
Ardent Health Stock Down 3.7%
Shares of NYSE ARDT traded down $0.49 during trading hours on Tuesday, hitting $12.82. The company had a trading volume of 2,359,669 shares, compared to its average volume of 286,704. The stock has a market capitalization of $1.83 billion, a P/E ratio of 7.08, a price-to-earnings-growth ratio of 5.88 and a beta of 0.30. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Ardent Health has a 1-year low of $10.10 and a 1-year high of $20.72. The firm's 50 day moving average is $12.21 and its 200-day moving average is $13.07.
Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.30 by $0.22. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%.The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, analysts expect that Ardent Health will post 1.23 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Ardent Health
Institutional investors and hedge funds have recently bought and sold shares of the company. Oliver Luxxe Assets LLC grew its position in shares of Ardent Health by 1.5% in the 2nd quarter. Oliver Luxxe Assets LLC now owns 87,639 shares of the company's stock valued at $1,197,000 after buying an additional 1,319 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health during the fourth quarter worth approximately $27,000. Geode Capital Management LLC boosted its stake in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock valued at $3,918,000 after purchasing an additional 1,769 shares during the last quarter. Squarepoint Ops LLC boosted its stake in Ardent Health by 1.8% during the 4th quarter. Squarepoint Ops LLC now owns 101,798 shares of the company's stock valued at $1,739,000 after purchasing an additional 1,798 shares during the last quarter. Finally, CWM LLC lifted its position in shares of Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company's stock worth $30,000 after buying an additional 2,001 shares in the last quarter.
About Ardent Health
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Featured Stories

Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.